Combes, Alain http://orcid.org/0000-0002-6030-3957
Schmidt, Matthieu
Hodgson, Carol L.
Fan, Eddy
Ferguson, Niall D.
Fraser, John F.
Jaber, Samir
Pesenti, Antonio
Ranieri, Marco
Rowan, Kathryn
Shekar, Kiran
Slutsky, Arthur S.
Brodie, Daniel
Article History
Received: 22 September 2020
Accepted: 10 October 2020
First Online: 2 November 2020
Compliance with ethical standards
:
: AC reports grants from Getinge, personal fees from Getinge, Baxter and Xenios outside the submitted work. AC is also the recent past president of the EuroELSO organization and a member of the executive and scientific committees for ECMONet. MS reported personal fees from Getinge, Drager, and Xenios, outside the submitted work. MS is also member of the Data Committee for ECMONet. CH is a member of the steering and scientific committees for ECMONet. EF reports personal fees from ALung Technologies, Fresenius Medical Care, Getinge, and MC3 Cardiopulmonary outside the submitted work. NF reports consulting fees from Getinge and Xenios. NF is a member of the executive and scientific committees for ECMONet. JF is current president of Asia Pacific ELSO, Exec of ECMOnet, and has received grant funding from Getinge, Xenios, Drager and CSL. He is co-founder of BiVACOR (mechanical support device). He declares no personal fees. SJ reports receiving consulting fees from Drager, Fresenius-Xenios, Baxter, Medtronic, and Fisher & Paykel. AP reports perrsonal fees for consulting/lectures from Maquet, Xenios, Baxter, and Boehringer Ingelheim. AS is on the medical advisory boards for Baxter and Xenios. Hs is Chair of the Scientific Committee of the International ECMO Network (ECMONet). DB receives research support from ALung Technologies. He has been on the medical advisory boards for Baxter, Abiomed, Xenios and Hemovent. DB is also the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet). The other authors declare that they have no conflicts of interest related to the purpose of this manuscript.
Free to read: This content has been made available to all.